Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer

Journal of Clinical Oncology

Volumn 15, Issue 1, 1997, Pages 292-296

  Kubota, K ^a   Nishiwaki, Y ^a   Kakinuma, R ^a   Hojo, F ^a   Matsumoto, T ^a   Ohmatsu, H ^a   Sekine, I ^a   Yokozaki, M ^a   Goto, K ^a   Ebi, N ^a   Kodama, T ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; GRANISETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUROPATHY; PRIORITY JOURNAL; RECURRENT CANCER; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031026188     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.1.292     Document Type: Article

References (31)

1. Tominaga S: Future prediction of cancer deaths in Japan. Jpn J Cancer Chemother 16:101-111, 1989
2. Arriagada R, Cosset JM, LeChevalier T, et al: The value of adjunctive radiotherapy when chemotherapy is the major curative method. Int J Radiat Oncol Biol Phys 19:1279-1284, 1990
3. Livingston RB, Trauth CJ, Greenstreet RL: Small cell carcinoma: Clinical manifestations and behavior with treatment, in Greco FA, Oldham RK, Bunn PA (eds): Small Cell Lung Cancer. Orlando, FL, Grune & Stratton, 1981, pp 285-300
4. Evans WK, Osoba D, Feld R, et al: Etoposide (VP-16) and cisplatin: An effective treatment for relapse in small-cell lung cancer. J Clin Oncol 3:65-71, 1985
5. Porter LL, Johnson DH, Hainsworth JD, et al: Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung. Cancer Treat Rep 69:479-481, 1985
6. Johnson DH: Treatment of relapsed small cell lung cancer. Lung Cancer 11:142-143, 1994 (suppl 2)
7. Masuda N, Fukuoka M, Matsui K, et al: Evaluation of high dose etoposide combined with cisplatin for treating relapsed small cell lung cancer. Cancer 65:2635-2640, 1990
8. Murray N, Shah A, Osoba D, et al: Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer. J Clin Oncol 9:1632-1638, 1991
9. Murray N: Weekly chemotherapy for small cell lung cancer. Lung Cancer 11:138-139, 1994 (suppl 2)
10. Fukuoka M, Takada M, Masuda N, et al: Dose intensive weekly chemotherapy (CT) with or without recombinant human granulocyte colony-stimulating factor (G-CSF) in extensive-stage (ES) small-cell lung cancer (SCLC). Proc Am Soc Clin Oncol 11:290, 1992 (abstr 967)
11. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset publication no. 48. Geneva, Switzerland, World Health Organization, 1979
12. Hryniuk WM, Goodyear M: The calculation of received dose intensity. J Clin Oncol 8:1935-1937, 1990 (editorial)
13. Longo DL, Duffey PL, DeVita VT et al: The calculation of actual or received dose intensity: A comparison of published methods. J Clin Oncol 9:2042-2051, 1991
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
15. Pignon JP, Arriagada R, Ihde DC, et al: A meta analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1618-1624, 1992
16. Murray N, Coy P, Pater JL, et al: Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small cell lung cancer. J Clin Oncol 11:336-344, 1993
17. Johnson DH, Kim K, Turrisi AT, et al: Cisplatin (C) & etoposide (E) + concurrent thoracic radiotherapy (TRT) administered once versus twice daily for limited-stage (LS) small cell lung cancer (SCLC): Preliminary results of an intergroup trial. Proc Am Soc Clin Oncol 13:333, 1994 (abstr 1105)
18. Turrisi AT, Glopver DJ, Mason BA: A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer, Int J Radiat Oncol Biol Phys 15:183-187, 1988
19. Johnson DH, Greco A, Strupp J, et al: Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: A phase II trial. J Clin Oncol 8:1613-1617, 1990
20. Masuda N, Fukuoka M, Kusunoki Y, et al: CPT-11: A new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer. J Clin Oncol 10:1225-1229, 1992
21. Faylona EA, Loehrer PJ, Ansari R, et al: Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: A Hoosier Oncology Group trial. J Clin Oncol 13:1209-1214, 1995
22. Murray N, Osoba D, Shah A, et al: Brief intensive chemotherapy for metastatic non-small-cell lung cancer: A phase II study of the weekly CODE regimen. J Natl Cancer Inst 83:190-194, 1991
23. Sehested M, Hirsch FR, Osterlind K, et al: Morphologic variations of small cell lung cancer: A histopathologic study of pretreatment and post treatment specimens in 104 patients. Cancer 57:804-807, 1986
24. Fukuoka M, Furuse K, Saijo N, et al: Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 83:855-861, 1991
25. Evans WK, Feld R, Murray N, et al: Superiority of alternating non-cross resistant chemotherapy in extensive small cell lung cancer. Ann Intern Med 107:451-458, 1987
26. Roth BJ, Johnson DH, Einhorn LH, et al: Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 10:282-291, 1992
27. Wampler GL, Heim WJ, Ellison NM, et al: Comparison of cyclophosphamide, doxorubicin, vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: A Mid-Atlantic Oncology Program study. J Clin Oncol 9:1438-1445, 1991
28. Giaccone G, Ferrati P, Donadio M, et al: Reinduction chemotherapy in small cell lung cancer. Eur J Cancer Clin Oncol 23:1697-1699, 1987
29. Postmus PE, Berendsen HH, VanZandwijk N, et al: Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy. Eur J Cancer Clin Oncol 23:1409-1411, 1987
30. Giaccone G: Identification of new drugs in pretreated patients with small-cell lung cancer. Eur J Cancer Clin Oncol 25:411-413, 1989
31. Batist G, Carney DN, Cowan KH, et al: Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: Clinical trial and in vitro correlates. J Clin Oncol 4:982-986, 1986